Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders

@article{Berg2020CirculatingMA,
  title={Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders},
  author={Merlijn van den Berg and Julian Krauskopf and Johannes G Ramaekers and Jos Kleinjans and Jos Prickaerts and Jacco J Bried{\'e}},
  journal={Progress in Neurobiology},
  year={2020},
  volume={185}
}
Circulating microRNAs (cimiRNAs) are a class of non-encoding RNAs found in bodily fluids such as blood, cerebrospinal fluid (CSF) and tears. CimiRNAs have been implicated as promising biomarkers for central nervous system (CNS) disorders because they are actively secreted as messengers and are profoundly involved in fine-tuning of developmental and differentiation processes. Furthermore, they are attractive biomarkers because they are extremely stable, tissue enriched and can be determined in a… Expand
Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders
TLDR
This review aims to critically evaluate the potential advantages and disadvantages of miRNAs as diagnostic/prognostic biomarkers in psychiatric disorders as well as in treatment response. Expand
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
TLDR
The significantly heterogeneous nature of miRNA expression and complexity in AD tissues and biofluids is highlighted and information may be extracted from these data to be used as a diagnostic, prognostic and/or screening tools across the entire continuum of AD. Expand
Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
TLDR
Recent advances in the detection of abnormally expressed miRNAs and lncRNAs in PD circulating fluids are reviewed and the determination of abnormalities in these biomarkers will be valuable for the future diagnosis and treatment of PD. Expand
Dysregulation of circRNA expression in the peripheral blood of individuals with schizophrenia and bipolar disorder.
TLDR
A comprehensive analysis of circRNA expression in peripheral blood mononuclear cells (PBMCs) from 39 patients with schizophrenia and bipolar disorder as well as 20 healthy individuals using deep RNA-seq identified 8762 high confidence circRNAs with systematic alternative splicing in human PBMCs. Expand
Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?
TLDR
The evidence supporting the involvement of non-coding RNA in MDD and BD and their potential use as biomarkers for treatment response is focused on. Expand
MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
TLDR
This review provides comprehensive information about the regulatory function of miRNAs in AD, as well as potential applications as diagnostic biomarkers and therapeutic value in this debilitating disease. Expand
A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
TLDR
This review recapitulate what is known about the sex-specific differences in peripheral miRNA levels in neurodegenerative diseases and shows that sex- specific biomarkers, such as miRNAs, could represent a useful tool for characterizing subgroups of patients. Expand
MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study
TLDR
Results under-line the necessity to examine the miRNA content of each EV subpopulation to identify miRNA candidates with potential diagnostic value and lay the basis for future studies to validate the overexpression of circulating miR-34a-5p in PD via the use of pure SEVs. Expand
Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
TLDR
This review article covers several candidate cerebrospinal fluid (CSF) biomarkers for PD based on the recent literature and meta-analysis data, and describes more hopeful biochemical markers, such as neurotransmitters, oxidative stress markers, and other candidate biomarkers. Expand
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
TLDR
This review article aims to summarize useful biomarkers for the diagnosis of PD, as well as the biomarkers used to monitor disease progression, and describes the role of α-Syn in PD and how it could potentially be used as a biomarker for PD. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 286 REFERENCES
Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders
TLDR
This review covers the increasing amounts of dataset that have accumulated in the last years on the use of circulating miRNAs and their values as potential biomarkers in most areas of neuropsychiatric diseases. Expand
The MiRNA Journey from Theory to Practice as a CNS Biomarker
TLDR
The goal of this review is to explore the prospective use of CSF miRNA as a reliable and affordable biomarker for different neurological disorders. Expand
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
TLDR
The findings support the potential of miRNA panels as biomarkers for movement disorders and may provide more insights into the pathological mechanisms related to these disorders. Expand
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases
TLDR
Although little is known about the origin and functions of circulating miRNAs at present, their roles in the clinical diagnosis and prognosis of diseases make them attractive markers, particularly for tumors and cardiovascular diseases. Expand
Circulating miRNAs as potential biomarkers in Alzheimer's disease.
TLDR
It is demonstrated that cell-free miR-125b serum levels are decreased in serum from patients with AD as compared with NINDC and distinguish between AD and NinDCs with an accuracy of 82%. Expand
Peripheral whole blood microRNA alterations in major depression and bipolar disorder.
TLDR
The observed results indicate a dysregulation of miRNA blood expression in mood disorders and could indicate new avenues for a better understanding of their pathogenetic mechanisms. Expand
Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder
TLDR
Potential contribution of miR-124-3p in the pathophysiology of MDD is demonstrated and it is suggested that this miRNA may serve as a novel target for drug development and a biomarker for MDD pathogenesis. Expand
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy
TLDR
The results suggest that cmiRNA signatures discriminate PD from MSA patients and healthy controls and may be considered specific, non-invasive biomarkers for differential diagnosis. Expand
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
TLDR
Results suggest that the decreased plasma miR-134 levels may be directly associated with the pathophysiology and severity of manic symptoms in BD and plasma miRNA-134 in BD may be considered as a potential peripheral marker that can respond to acute manic episodes and associate with effective mood stabilizers treatment. Expand
MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
TLDR
The qRT-PCR results provide a possibility that miRNAs detected in plasma and CSF can serve as biomarkers for AD. Expand
...
1
2
3
4
5
...